IDEAS home Printed from https://ideas.repec.org/f/pgu273.html
   My authors  Follow this author

Samira Guennif

Personal Details

First Name:Samira
Middle Name:
Last Name:Guennif
Suffix:
RePEc Short-ID:pgu273

Affiliation

Centre d'Économie de l'Université Paris-Nord (CEPN)
Université Paris-13

Paris, France
http://cepn.univ-paris13.fr/

: 33 (0)1 49 40 33 18
01 49 40 33 34
99, avenue Jean-Baptiste Clément, 93430 Villetaneuse
RePEc:edi:cep13fr (more details at EDIRC)

Research output

as
Jump to: Working papers Articles Chapters Books

Working papers

  1. Guennif, Samir & Ramani, Shyama, 2010. "Catching up in pharmaceuticals: a comparative study of India and Brazil," MERIT Working Papers 019, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
  2. Samira Guennif, 2009. "Aids In India," Working Papers id:1974, eSocialSciences.
  3. Samira Guennif, 2007. "Enjeux de santé publique sous gouvernance globale de la propriété intellectuelle. De l'usage des flexibilités prévues par l'ADPIC au Sud," CEPN Working Papers halshs-00176508, HAL.
  4. Samira Guennif, 2007. "Protection du brevet et promotion de la santé publique selon les accords de libre échange états-uniens : surenchères autour des standards minimums de l'AADPIC au Sud," CEPN Working Papers halshs-00176509, HAL.
  5. Valérie Revest & Samira Guennif, 2005. "Social structure and reputation: the NASDAQ case study," Post-Print halshs-00163731, HAL.

Articles

  1. Samira Guennif, 2012. "L'économie politique du brevet au Sud : dimensions industrielle et sanitaire," Mondes en développement, De Boeck Université, vol. 0(4), pages 85-98.
  2. Guennif, Samira & Ramani, Shyama V., 2012. "Explaining divergence in catching-up in pharma between India and Brazil using the NSI framework," Research Policy, Elsevier, vol. 41(2), pages 430-441.
  3. Samira Guennif & Julien Chaisse, 2007. "L'économie politique du brevet au sud : variations Indiennes sur le brevet pharmaceutique," Revue internationale de droit économique, De Boeck Université, vol. 0(2), pages 185-210.
  4. Samira Guennif & Claude Mfuka, 2005. "L'accès aux traitements antisida en Afrique : une analyse de la stratégie de brevet des entreprises multinationales," Mondes en développement, De Boeck Université, vol. 131(3), pages 75-86.
  5. Samira Guennif, 2002. "From knowledge to individual action. Confidence, the hidden face of uncertainty. A rereading of the works of Knight and Keynes," Mind & Society: Cognitive Studies in Economics and Social Sciences, Springer;Fondazione Rosselli, vol. 3(2), pages 13-28, September.

Chapters

  1. Shyama V. Ramani & Samira Guennif, 2012. "Catching up in the Pharmaceutical Sector: Lessons from Case Studies of India and Brazil," Chapters,in: Economic Development as a Learning Process, chapter 5 Edward Elgar Publishing.
  2. Kenneth C. Shadlen & Samira Guennif & Alenka Guzmán & N. Lalitha, 2011. "Globalization, Intellectual Property Rights, and Pharmaceuticals: Meeting the Challenges to Addressing Health Gaps in the New International Environment," Chapters,in: Intellectual Property, Pharmaceuticals and Public Health, chapter 1 Edward Elgar Publishing.
  3. Samira Guennif, 2011. "Access to Essential Drugs in Thailand: Intellectual Property Rights and Other Institutional Matters Affecting Public Health in a Developing Country," Chapters,in: Intellectual Property, Pharmaceuticals and Public Health, chapter 11 Edward Elgar Publishing.

Books

  1. Kenneth C. Shadlen & Samira Guennif & Alenka Guzmán & Narayanan Lalitha (ed.), 2011. "Intellectual Property, Pharmaceuticals and Public Health," Books, Edward Elgar Publishing, number 13876.

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Working papers

  1. Guennif, Samir & Ramani, Shyama, 2010. "Catching up in pharmaceuticals: a comparative study of India and Brazil," MERIT Working Papers 019, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).

    Cited by:

    1. Daems, Rutger & Maes, Edith & Ramani, Shyama V., 2011. "Global Framework for Differential Pricing of Pharmaceuticals," MERIT Working Papers 054, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
    2. Varma, Sumati & Nayyar, Rishika, 2014. "OFDI between India and the LAC Region : A firm level motive analysis," MPRA Paper 56219, University Library of Munich, Germany.

  2. Samira Guennif, 2009. "Aids In India," Working Papers id:1974, eSocialSciences.

    Cited by:

    1. Veronique Dupont & Sridharan N, 2007. "Peri-Urban Dynamics: Case studies in Chennai, Hyderabad and Mumbai," Working Papers id:974, eSocialSciences.
    2. Renaud Egreteau, 2010. "Instability at the Gate: India’s Troubled Northeast and its External Connections," Working Papers id:2547, eSocialSciences.
    3. Deepa Menon Choudhary & Amit Garg & P.R Shukla, 2009. "Assessing Policy Choices For Managing SO2 Emisions From Indian Power Sector," Working Papers id:1957, eSocialSciences.
    4. Sébastien Oliveau, 2007. "Periurbanisation in Tamil Nadu: A Quantitative Approach," Working Papers id:1228, eSocialSciences.
    5. Nicolas Gravel & Abhiroop Mukhopadhyay, 2007. "Is India Better off Today than 15 Years ago? A Robust Multidimensional Answer," IDEP Working Papers 0704, Institut d'economie publique (IDEP), Marseille, France, revised 18 May 2007.
    6. Guennif, Samira & Ramani, Shyama V., 2012. "Explaining divergence in catching-up in pharma between India and Brazil using the NSI framework," Research Policy, Elsevier, vol. 41(2), pages 430-441.
    7. Samira Guennif, 2007. "Global harmonisation of intellectual property rights and local impact. Patent and access to medicines in developing countries under TRIPS and TRIPS plus provisions
      [Harmonisation globale des systèm
      ," Post-Print hal-01345869, HAL.
    8. Laurence Henry, 2007. "Trade and Economic Arrangements Between India and South Asia in the Context of Regional Construction and Globalisation," Working Papers id:1055, eSocialSciences.

Articles

  1. Samira Guennif, 2012. "L'économie politique du brevet au Sud : dimensions industrielle et sanitaire," Mondes en développement, De Boeck Université, vol. 0(4), pages 85-98.

    Cited by:

    1. Abecassis, Philippe & Coutinet, Nathalie, 2015. "Médicaments génériques : pivot de la reconstruction de l’industrie pharmaceutique," Revue de la Régulation - Capitalisme, institutions, pouvoirs, Association Recherche et Régulation, vol. 17.

  2. Guennif, Samira & Ramani, Shyama V., 2012. "Explaining divergence in catching-up in pharma between India and Brazil using the NSI framework," Research Policy, Elsevier, vol. 41(2), pages 430-441.

    Cited by:

    1. Landini, Fabio & Lee, Keun & Malerba, Franco, 2017. "A history-friendly model of the successive changes in industrial leadership and the catch-up by latecomers," Research Policy, Elsevier, vol. 46(2), pages 431-446.
    2. Schüren Verena, 2013. "What a difference a state makes: pharmaceutical innovation after the TRIPs agreement," Business and Politics, De Gruyter, vol. 15(2), pages 217-243, August.
    3. Loitongbam, Bishwanjit Singh, 2016. "Impact of TRIPS and RTAs on the Indian Pharmaceutical Product Exports," MPRA Paper 75764, University Library of Munich, Germany, revised 27 May 2016.
    4. Loitongbam, Bishwanjit Singh, 2016. "Globalization and Innovation in the Indian Pharmaceutical Industry," MPRA Paper 75925, University Library of Munich, Germany, revised 27 May 2016.
    5. Keun Lee & Tae Young Park & Rishikesha T. Krishnan, 2014. "Catching-up or Leapfrogging in the Indian IT Service Sector: Windows of Opportunity, Path-creating, and Moving up the Value Chain," Development Policy Review, Overseas Development Institute, vol. 32(4), pages 495-518, July.
    6. Anil Nair & Orhun Guldiken & Stav Fainshmidt & Amir Pezeshkan, 2015. "Innovation in India: A review of past research and future directions," Asia Pacific Journal of Management, Springer, vol. 32(4), pages 925-958, December.
    7. Chung, Chao-chen, 2013. "Government, policy-making and the development of innovation system: The cases of Taiwanese pharmaceutical biotechnology policies (2000–2008)," Research Policy, Elsevier, vol. 42(5), pages 1053-1071.
    8. Khayyat, Nabaz T. & Lee, Jeong-Dong, 2015. "A measure of technological capabilities for developing countries," Technological Forecasting and Social Change, Elsevier, vol. 92(C), pages 210-223.

  3. Samira Guennif & Julien Chaisse, 2007. "L'économie politique du brevet au sud : variations Indiennes sur le brevet pharmaceutique," Revue internationale de droit économique, De Boeck Université, vol. 0(2), pages 185-210.

    Cited by:

    1. Samira Guennif, 2007. "Enjeux de santé publique sous gouvernance globale de la propriété intellectuelle. De l'usage des flexibilités prévues par l'ADPIC au Sud," CEPN Working Papers halshs-00176508, HAL.
    2. Samira Guennif, 2007. "Enjeux de santé publique sous gouvernance globale de la propriété intellectuelle. De l'usage des flexibilités prévues par l'ADPIC au Sud," Working Papers halshs-00176508, HAL.
    3. Samira Guennif, 2007. "Global harmonisation of intellectual property rights and local impact. Patent and access to medicines in developing countries under TRIPS and TRIPS plus provisions
      [Harmonisation globale des systèm
      ," Post-Print hal-01345869, HAL.

Chapters

  1. Shyama V. Ramani & Samira Guennif, 2012. "Catching up in the Pharmaceutical Sector: Lessons from Case Studies of India and Brazil," Chapters,in: Economic Development as a Learning Process, chapter 5 Edward Elgar Publishing.

    Cited by:

    1. Jun-Youn Kim & Tae-Young Park & Keun Lee, 2013. "Catch-Up by Indigenous Firms in the Software Industry and the Role of the Government in China: A Sectoral System of Innovation (SSI) Perspective," Eurasian Business Review, Springer;Eurasia Business and Economics Society, vol. 3(1), pages 100-120, June.

  2. Samira Guennif, 2011. "Access to Essential Drugs in Thailand: Intellectual Property Rights and Other Institutional Matters Affecting Public Health in a Developing Country," Chapters,in: Intellectual Property, Pharmaceuticals and Public Health, chapter 11 Edward Elgar Publishing.

    Cited by:

    1. Samira Guennif, 2017. "Is Compulsory Licensing Bad for Public Health? Some Critical Comments on Drug Accessibility in Developing Countries," Applied Health Economics and Health Policy, Springer, vol. 15(5), pages 557-565, October.
    2. Guennif, Samira, 2015. "La licence obligatoire : outil emblématique de la protection de la santé publique au Sud," Revue de la Régulation - Capitalisme, institutions, pouvoirs, Association Recherche et Régulation, vol. 17.

Books

  1. Kenneth C. Shadlen & Samira Guennif & Alenka Guzmán & Narayanan Lalitha (ed.), 2011. "Intellectual Property, Pharmaceuticals and Public Health," Books, Edward Elgar Publishing, number 13876.

    Cited by:

    1. Guennif, Samira, 2015. "La licence obligatoire : outil emblématique de la protection de la santé publique au Sud," Revue de la Régulation - Capitalisme, institutions, pouvoirs, Association Recherche et Régulation, vol. 17.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Co-authorship network on CollEc

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 2 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-CWA: Central & Western Asia (1) 2009-05-30
  2. NEP-HIS: Business, Economic & Financial History (1) 2010-04-17

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Samira Guennif should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.